SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
10-Oct-24 8:39 PM View: | Enliven Therapeutics, Inc. (ELVN) | 09-Oct-24 | Sale (Planned) | 37,878 | $28.16 | $1,066,560.00 | (4%) 1.05M to 1.02M | |
10-Oct-24 8:39 PM View: | Enliven Therapeutics, Inc. (ELVN) | 08-Oct-24 | Private Sale (Planned) | 13,267 | $27.97 | $371,024.00 | (1%) 1.07M to 1.05M | |
08-Oct-24 6:58 PM View: | Enliven Therapeutics, Inc. (ELVN) | 07-Oct-24 | Sale (Planned) | 2,707 | $27.61 | $74,727.00 | (< 1%) 1.07M to 1.07M | |
08-Oct-24 6:58 PM View: | Enliven Therapeutics, Inc. (ELVN) | 04-Oct-24 | Private Sale (Planned) | 7,522 | $27.51 | $206,937.00 | (< 1%) 1.08M to 1.07M | |
03-Sep-24 5:43 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Aug-24 | Private Sale (Planned) | 12,000 | $22.49 | $269,841.00 | (1%) 1.09M to 1.08M | |
02-Aug-24 7:26 PM View: | Enliven Therapeutics, Inc. (ELVN) | 31-Jul-24 | Private Sale (Planned) | 3,099 | $27.56 | $85,399.50 | (< 1%) 1.09M to 1.09M | |
31-Jul-24 7:33 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Jul-24 | Private Sale (Planned) | 12,000 | $26.70 | $320,378.00 | (1%) 1.11M to 1.09M | |
03-Jul-24 4:31 PM View: | Enliven Therapeutics, Inc. (ELVN) | 01-Jul-24 | Private Sale (Planned) | 12,000 | $22.89 | $274,736.00 | (1%) 1.12M to 1.11M | |
31-May-24 4:05 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-May-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | 1% 1.12M to 1.13M | |
31-May-24 4:05 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-May-24 | Planned Option Sale | 12,000 | $21.73 | $260,800.00 | (1%) 1.13M to 1.12M | |
01-May-24 7:04 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Apr-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | 1% 1.12M to 1.13M | |
01-May-24 7:04 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Apr-24 | Planned Option Sale | 12,000 | $17.92 | $214,988.00 | (1%) 1.13M to 1.12M | |
15-Apr-24 7:06 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Option Exercise | 30,000 | $1.12 | $33,600.00 | 3% 1.12M to 1.15M | |
15-Apr-24 7:06 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Planned Option Sale | 30,000 | $25.04 | $751,332.00 | (3%) 1.15M to 1.12M | |
03-Apr-24 9:30 PM View: | Enliven Therapeutics, Inc. (ELVN) | 01-Apr-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | 1% 1.12M to 1.13M | |
03-Apr-24 9:30 PM View: | Enliven Therapeutics, Inc. (ELVN) | 01-Apr-24 | Planned Option Sale | 12,000 | $18.60 | $223,146.00 | (1%) 1.13M to 1.12M | |
04-Mar-24 5:55 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Feb-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | 1% 1.12M to 1.13M | |
04-Mar-24 5:55 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Feb-24 | Planned Option Sale | 12,000 | $16.42 | $197,006.00 | (1%) 1.13M to 1.12M | |
31-Jan-24 9:22 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Jan-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | 1% 1.12M to 1.13M | |
31-Jan-24 9:22 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Jan-24 | Planned Option Sale | 12,000 | $15.85 | $190,256.00 | (1%) 1.13M to 1.12M | |
03-Jan-24 7:01 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Dec-23 | Option Exercise | 12,000 | $1.12 | $13,440.00 | 1% 1.12M to 1.13M | |
03-Jan-24 7:01 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Dec-23 | Planned Option Sale | 12,000 | $14.28 | $171,381.00 | (1%) 1.13M to 1.12M | |
26-Dec-23 7:32 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Dec-23 | Option Exercise | 6,546 | $1.12 | $7,331.52 | < 1% 1.12M to 1.12M | |
26-Dec-23 7:32 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Dec-23 | Planned Option Sale | 6,546 | $13.07 | $85,530.00 | (< 1%) 1.12M to 1.12M | |
26-Dec-23 7:32 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Dec-23 | Option Exercise | 20 | $1.12 | $22.40 | < 1% 1.12M to 1.12M | |
26-Dec-23 7:32 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Dec-23 | Planned Option Sale | 20 | $13.00 | $260.00 | (< 1%) 1.12M to 1.12M | |
21-Dec-23 4:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Dec-23 | Option Exercise | 8,688 | $1.12 | $9,730.56 | < 1% 1.12M to 1.13M | |
21-Dec-23 4:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Dec-23 | Planned Option Sale | 8,688 | $13.01 | $113,046.00 | (< 1%) 1.13M to 1.12M | |
21-Dec-23 4:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 19-Dec-23 | Option Exercise | 200 | $1.12 | $224.00 | < 1% 1.12M to 1.12M | |
21-Dec-23 4:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 19-Dec-23 | Planned Option Sale | 200 | $13.00 | $2,600.00 | (< 1%) 1.12M to 1.12M | |
06-Nov-23 4:43 PM View: | Enliven Therapeutics, Inc. (ELVN) | 03-Nov-23 | Option Exercise | 8,546 | $1.12 | $9,571.52 | < 1% 1.12M to 1.13M | |
06-Nov-23 4:43 PM View: | Enliven Therapeutics, Inc. (ELVN) | 03-Nov-23 | Planned Option Sale | 8,546 | $13.08 | $111,751.00 | (< 1%) 1.13M to 1.12M | |
03-Oct-23 10:00 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Sep-23 | Option Exercise | 12,000 | $1.12 | $13,440.00 | 1% 1.12M to 1.13M | |
03-Oct-23 10:00 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Sep-23 | Planned Option Sale | 12,000 | $13.62 | $163,498.00 | (1%) 1.13M to 1.12M | |
27-Feb-23 9:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant | 1,117,040 | -- | -- | 100% 0 to 1.12M |